This is how the World Economic Forum is supporting COVID-19 vaccination

AstraZeneca's COVISHIELD vaccine is in the COVAX research and development portfolio. Image: REUTERS/Francis Mascarenhas

Kate Whiting
Senior Writer, Forum Agenda
Martina Szabo
Head of Knowledge Communities, World Economic Forum
Our Impact
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:


Have you read?
Gavi's impact draws on the strength of its core partners
How Gavi works in collaboration with other global partners. Image: Gavi
Social media cards - ACT (Access to COVID-19 Tools accelerator)
How the ACT-Accelerator is working to deliver vaccines to all. Image: WHO

What is the World Economic Forum doing about access to vaccines?

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
COVID-19VaccinationGlobal Health
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Here's how air pollution increases COVID risk

Samuel J. White and Philippe B. Wilson

March 23, 2023

About Us



Partners & Members

  • Join us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum